The presentation will cover the main features of the disease, the rational for conducting our research and the work we have been carrying out using MVA based vaccines to prevent AHS. We are working on other aspects of the disease but will not have time to talk much about other subjects. These include pathogenesis, epitope mapping and immuno-therapy.
